Skip to content
Log in
Sponsored AI Networking Cookbook: Practical recipes for AI-assisted network automation and development AI Networking Cookbook: Practical recipes for AI-assisted network automation and development

Elevated Expression of LINC02257 and LINC00659 in Breast Cancer is Associated with Poor Survival and Immune Cell Infiltration

Fatemeh Badzohre Azin Azadfekr Farnoosh Akbari Azra Pourhashem Ensieh Sagheb Sadeghi Atefeh Zamani Mohammad Mahdevar
Aug 2026 · Current Genetic Medicine Reports · Vol 14 · 0 citations · 32 references

TL;DR

This study found that LINC02257 and LINC00659 are upregulated in BC and are associated with malignancy-related genes and patient survival, suggesting their potential as therapeutic targets and prognostic biomarkers.

DOI Semantic Scholar
View source

Similar papers

Open access Aug 2026

Long Noncoding RNAs (lncRNAs) as Biomarkers of Prognosis in TNBC and Non-TNBC Breast Cancer Patients

This computational study identifies several candidate lncRNAs associated with clinical outcomes in breast cancer, which should be interpreted as preliminary candidates, which require future validation and functional studies to determine their biological roles and evaluate their potential as prognostic biomarkers.

M. Acencio, Xin-Hui Wang, Flavia R. Rotea Mangone et al. · 0 citations
Open access Jul 2026

LINC00673-V4 Promotes Colorectal Cancer Cell Proliferation by Interacting With FUS and Restoring the Expression of Hippo-YAP Target Genes.

This study investigated how LINC00673-V4 drives CRC proliferation by modulating the Hippo-Yes-associated protein (Hippo-YAP) signaling pathway and identified LINC00673-V4 as an isoform-specific oncogenic lncRNA in CRC.

Wei Lu, Jiamin Zhong, Yunxiang Zhou et al. · 0 citations
Open access 2026

LINC00460 drives clear cell renal cell carcinoma progression via complement/coagulation and p53 pathways: a potential therapeutic target.

Findings establish LINC00460 as an oncogenic driver in ccRCC and a promising target for both diagnosis and precision therapy and identifies cinchonine and iproniazid as candidate therapeutic agents.

Bo Dong, Songtao Liu, Wenyu Wang et al. · 0 citations
Open access Jul 2026

LINC01133 knockout increases malignancy by migration mechanisms in Hs578T Triple-Negative Breast Cancer Cells

Analysis of the impact of LINC01133 depletion on malignant phenotypes and on the expression of migration- and invasion-associated genes using the Hs578T triple-negative breast cancer cell line indicates that LINC01133 acts as a potential fine regulator of in vitro migration and invasion processes in TNBC.

H. C. Jesus-Ferreira, Leandro Teodoro, Ana C. O. Carreira et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.